Production of DCN in B cells has been demonstrated in the setting of early stage B cell chronic lymphocytic leukaemia [42] and further clinical and preclinical studies are needed to elucidate their functional and prognostic significance in solid tumours. This evidence concerns the gene DCN and B-cell chronic lymphocytic leukemia.